Search - tctmd.com

Displaying 681 - 700 of 849

Sort: Relevancy | Date

Presentation ECHO 2017

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Presenter: Florian Deuschl

March 31, 2017

Presentation ECHO 2017

Echo Hemodynamics II: Echo Quantification of Valvular Regurgitation

Presenter: Linda D. Gillam

March 31, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

Podcast Heart Sounds ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Daily News

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

Yael L. Maxwell

March 27, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

Michael O'Riordan

March 24, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Shelley Wood

March 23, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

Todd Neale

March 22, 2017

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

L.A. McKeown

March 21, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

News Conference News ACC 2017

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Caitlin E. Cox

March 20, 2017

News Conference News ACC 2017

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Todd Neale

March 19, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Two

Shelley Wood

March 18, 2017

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: First Results from the SURTAVI Clinical Trial

Presentation ACC 2017

First Results from the SURTAVI Clinical Trial

Presenter: Michael J. Reardon

March 17, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

Advertisement

3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement

Echo Hemodynamics II: Echo Quantification of Valvular Regurgitation

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Top Stories in Cardiology, March 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Simplified MRI Imaging Tests May Help ID Kids at High CV Risk During Sports

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

FDA Approves Next-Gen CoreValve Evolut PRO Valve

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Live From Washington: ACC 2017, Day Three

Live From Washington: ACC 2017, Day Two

First Results from the SURTAVI Clinical Trial

Live From Washington: ACC 2017, Day One

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content